DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Rea DW, Gray RG, Bowden SJ.
Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer.
Eur J Cancer 2013;
49: S402
We do not assume any responsibility for the contents of the web pages of other providers.